학술논문
Atezolizumab plus chemotherapy versus placebo plus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130): final overall survival analysis results from a randomised, controlled, phase 3 study
Document Type
Article
Author
Grande, E.; Arranz, J.Á.; De Santis, M.; Bamias, A.; Kikuchi, E.; del Muro, X.G.; Park, S.H.; De Giorgi, U.; Alekseev, B.; Mencinger, M.; Izumi, K.; Schutz, F.A.; Puente, J.; Li, J.-R.; O'Donnell, P.H.; Kalebasty, A.R.; Ye, D.; Mariathasan, S.; Bene-Tchaleu, F.; Bernhard, S.; Lee, C.; Davis, I.D.; Galsky, M.D.
Source
In: The Lancet Oncology . (The Lancet Oncology, January 2024, 25(1):29-45)
Subject
Language
English
ISSN
14745488
14702045
14702045